`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Sawai USA, Inc., Sawai Pharmaceutical Co., Ltd.,
`Petitioners,
`
`v.
`
`Nissan Chemical Industries, Ltd.,
`Patent Owner
`
`U.S. Patent No. 5,856,336
`
`Issue Date: January 5, 1999
`
`Title: Quinoline Type Mevalonolactones
`
`Inter Partes Review No. IPR 2015-01647
`
`POWER OF ATTORNEY
`UNDER 37 C.F.R. § 42.10
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner Nissan Chemical Industries,
`
`Ltd. hereby appoints the practitioners associated with Mintz Levin Cohn Ferris
`
`Glovsky and Popeo, P.C. as its attorneys to transact all business before the Patent
`
`Trial and Appeal Board of the United States Patent & Trademark Office in
`
`connection with all inter• partes review proceedings involving U.S. Patent No.
`
`5,856,336. Lead and backup counsel are separately designated in Patent Owner's
`
`Mandatory Notice.
`
`The undersigned is authorized to sign on behalf of Patent Owner
`
`By:
`
`For: Nissan Chemical Industries, Ltd., Patent Owner
`
`Name: Takuya Kakuta
`
`Senior Managing Associate Executive Officer
`Title: Head of Intellectual Property Department
`
`Date:
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner's Power of Attorney was served on August 20, 2015 by sending a copy by
`
`overnight courier and by email to:
`
`Kenneth J. Burchfiel
`Sughrue Mion, PLLC
`2100 Pennsylvania Ave., NW
`Washington, DC 20037
`kburchfiel@sughrue.corn
`
`/David G. Conlin/
`
`David G. Conlin
`Reg. No. 27,026